Prognostic value of measuring serum laminin levels in advanced cirrhosis of the liver;Klinischer Wert der Lamininbestimmung bei fortgeschrittener Leberzirrhose

Deutsche Medizinische Wochenschrift

Volumn 121, Issue 31-32, 1996, Pages 965-970

  Korner Th ^a,b   Kropf, J ^a   Gressner, A M ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Klinikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ;

ADULT; AGED; ARTICLE; ASCITES; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC COMA; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; MALE; MULTIPLE ORGAN FAILURE; PORTAL HYPERTENSION; PORTAL VEIN THROMBOSIS; PROGNOSIS;

EID: 0029982862     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043093     Document Type: Article

References (29)

1. Ballmer, P. E., D. Walshe, M. A. McNurlan, H. Watson, P. W. Brunt, P. J. Garlick: Albumin synthesis rates in cirrhosis: Correlation with Child-Turotte classification. Hepatology 18 (1993), 292-297.
2. Brailon, A., C. Gaudin, J. L. Poo, R. Moreau, B. Debaene, D. Lebrec: Plasma catecholamine concentrations are a reliable index of sympathetic vascular tone in patients with cirrhosis. Hepatology 15 (1992), 58-62.
3. Child, C. G., J. G. Turcotte: Surgery and portal hypertension. In Child, C. G. (Ed.): The Liver And Portal Hypertension. (Saunders: Philadelphia 1964), 50-72.
4. Christensen, E., P. Schlichting, L. Fauerholdt, C. Gluud, P. K. Andersen, E. Juhl, H. Poulsen, N. Tygstrup and the Copenhagen Study Group for Liver Diseases: Prognostic value of Child-Turcotte criteria in medically treated cirrhosis. Hepatology 4 (1984), 430-435.
5. Collazos, J., F. Diaz, J. Genolla: Serum concentrations of laminin in cirrhosis of the liver. Gut 34 (1993), 974-976.
6. Diaz, F., J. Collazos, J. Genolla: Serum laminin levels offer only a little additional Information in liver disease. J. clin. Gastroenterol. 18 (1994), 114-117.
7. Gressner, A. M., W. Tittor: Serum Laminin. Its concentration increases with portal hypertension in cirrhotic liver disease. Klin. Wschr. 64 (1986), 1240-1248.
8. Gressner, A. M., W. Tittor, J. Kropf: The predictive value of serum laminin for portal hypertension in chronic liver diseases. Hepato-Gastroenterol. 35 (1988), 95-100.
9. Gressner, A. M.: Perspectives in pathobiochemical research and clinical outlook. Europ. J. clin. Chem. Biochem. 29 (1991), 293-311.
10. Hortnagl, H., E. Singer, K. Lenz, G. Kleinberger, H. Lichs: Substance P is markedly increased in plasma of patients with hepatic coma. Lancet 323 (1984), 480-483.
11. Hunt, S., C. A. Vaamonde, T. Rattassi, G. Berian, S. I. Said, S. Paper: Circulating levels of vasoactive intestinal polypeptide in liver disease. Arch. intern. Med. 139 (1979), 994-996.
12. Körner, Th., F. W. Rath, H. Schmidt: The ability of cultivated human skin fibroblasts to store vitamin A. A contribution to the cytogenesis of the Ito-cells of the liver. Exp. Pathol. 35 (1988), 247-251.
13. Kropf, J., A. M. Gressner, A. Negwer: Efficacy of serum laminin measurement for fibrotic liver diseases. Clin. Chem. 34 (1988), 2026-2030.
14. Lotterer, E., A. M. Gressner, J. Kropf, E. Grobe, D. von Knebel, J. Bircher: Higher levels of serum aminoterminal type III procollagen peptide, and laminin in alcoholic than in nonalcoholic cirrhoses of equal severity. J. Hepatol. 14 (1992), 71-77.
15. Maher, J. J., S. L. Friedman, F. J. Roll, D. M. Bissell: Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture. Gastroenterology 94 (1988), 1053-1062.
16. Maier, K.-P.: Leberzirrhose. In Maier, K.-P.: Hepatitis - Hepatitisfolgen (Thieme: Stuttgart 1965), 198-257.
17. Martin, G. R., R. Timple: Laminin and other basement membrane components. Ann. Rev. Cell. Biol. 3 (1987), 57-85.
18. Meng, H.-C., H. C. Lin, A. T. Tsai, F. Y. Lee, D. M. Liao, H. C. Hsia, W. J. Lin, T. T. Chang, C. S. Lay, S. S. Wang, S. D. Lee, K. J. Lo: Relationships between the severity of cirrhosis and haemodynamic values in patients with cirrhosis. J. Gastroenterol. Hepatol. 9 (1994), 148-153.
19. Niemela, O., J. E. Blake, H. Orrego: Serum type I collagen propeptide and severity of alcoholic liver disease. Alcohol. Clin. exp. Res. 16 (1992), 1064-1067.
20. Plebani, M., A. Giacomini, A. Floreani: Biochemical markers of hepatic fibrosis in primary biliary cirrhosis. Res. clin. Lab. 20 (1990), 269-273.
21. Pugh, R. N. H., I. M. Murray-Lyon, J. L. Dawson, M.C. Pietroni, R. Williams: Transection of the oesophagus for bleeding oesophageal varices. Brit. J. Surg. 60 (1973), 646-649.
22. Sherlock, S., J. Dooley: The portal venous system and portal hypertension. In Sherlock, S., J. Dooley (Ed.): Diseases of The Liver And Biliary System, 9th ed. (Blackwell Scientific Publication: Oxford 1993), 132-178.
23. Silva, G., M. Navasa, J. Bosch: Hemodynamic effects of glucagon in portal hypertension. Hepatology 11 (1990), 668-673.
24. Siringo, S., L. Bolondi, S. Gaiani, S. Sofia, G. Di Febo, G. Zironi, A. Rigamonti, M. Miglioli, G. Cavalli, L. Barbara: The relationship of endoscopy, portal Doppler ultrasound flowmetry, and clinical and biochemical tests in cirrhosis. J. Hepatol. 20 (1994), 11-18.
25. Stark, M. E., J. H. Szurszewski: Role of nitric oxide in gastrointestinal and hepatic function and disease. Gastroenterology 103 (1992), 1928-1949.
26. Sugimura, T., Y. Tsuji, M. Sakamoto, K. Kotoh, T. Fukutomi, H. Sakai, S. Sakamoto, K. Akazawa, Y. Nose, H. Nawata: Long-term prognosis and prognostic factors of liver cirrhosis in the 1980s. J. Gastroenterol. Hepatol. 9 (1994), 154-161.
27. Tanikawa, K.: Serum marker for hepatic fibrosis and related liver pathology. Pathol. Res. Pract. 190 (1994), 960-968.
28. Timple, R., H. Ronde, P. G. Robey: Laminin. A glycoprotein from basement membranes. J. biol. Chem. 254 (1979), 9933-9937.
29. Willet, I., M. Esler, F. Burke, P. Leonhard, F. Dudley: Total and renal sympathetic nervous system activity in alcoholic cirrhosis. J. Hepatol. 1 (1985), 639-648.